{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:47:46Z","timestamp":1789084066194,"version":"build-2803163510"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n               <jats:p>The real-world incidence of JAK inhibitor-associated acne (JAKne) in patients with inflammatory bowel disease is significantly higher than reported in clinical trials. Younger age, female sex, and higher dosage have been identified as potential risk factors.<\/jats:p>","DOI":"10.1093\/ibd\/izaf115","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:50:21Z","timestamp":1748076621000},"page":"2311-2314","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-1784","authenticated-orcid":false,"given":"David","family":"Choi","sequence":"first","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Kellar","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Klein","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie K","family":"Choi","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M","family":"Garcia","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Friedberg","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Rubin","sequence":"additional","affiliation":[{"name":"University of Chicago Medicine Inflammatory Bowel Disease Center , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"1","key":"2025081217442335200_CIT0001","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.1038\/s41598-020-67710-2","article-title":"Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach","volume":"10","author":"Garc\u00eda","year":"2020","journal-title":"Sci Rep."},{"issue":"10341","key":"2025081217442335200_CIT0002","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","article-title":"Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials","volume":"399","author":"Danese","year":"2022","journal-title":"Lancet."},{"issue":"21","key":"2025081217442335200_CIT0003","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N Engl J Med."},{"issue":"9","key":"2025081217442335200_CIT0004","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.cgh.2022.11.029","article-title":"Upadacitinib therapy reduces ulcerative colitis symptoms as early as day 1 of induction treatment","volume":"21","author":"Loftus","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"7","key":"2025081217442335200_CIT0005","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.cgh.2023.03.001","article-title":"Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn\u2019s disease: prospective real-world experience","volume":"21","author":"Friedberg","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"2025081217442335200_CIT0006","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jaad.2022.06.012","article-title":"Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: a post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials","volume":"87","author":"Mendes-Bastos","year":"2022","journal-title":"J Am Acad Dermatol."},{"issue":"12","key":"2025081217442335200_CIT0007","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/jamadermatol.2023.3830","article-title":"Janus kinase inhibitors and adverse events of acne: a systematic review and meta-analysis","volume":"159","author":"Martinez","year":"2023","journal-title":"JAMA Dermatology"},{"key":"2025081217442335200_CIT0008","article-title":"Acne vulgaris","author":"Sutaria","year":"2023","journal-title":"StatPearls"},{"issue":"Supplement_1","key":"2025081217442335200_CIT0009","doi-asserted-by":"publisher","first-page":"i2206","DOI":"10.1093\/ecco-jcc\/jjad212.1379","article-title":"N07 JAKne: JAK inhibitor associated acne, a real-life single-center experience","volume":"18","author":"De Dycker","year":"2024","journal-title":"J. Crohns Colitis.."},{"issue":"Supplement_1","key":"2025081217442335200_CIT0010","doi-asserted-by":"publisher","first-page":"i2116","DOI":"10.1093\/ecco-jcc\/jjae190.1333","article-title":"P1159 New onset acne reported in the majority of patients with upadacitinib-treated inflammatory bowel disease","volume":"19","author":"Omrani","year":"2025","journal-title":"J. Crohns Colitis."},{"issue":"2","key":"2025081217442335200_CIT0011","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.clindermatol.2016.10.007","article-title":"Drug-induced acne","volume":"35","author":"Kazandjieva","year":"2017","journal-title":"Clin Dermatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf115\/63328654\/izaf115.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2311\/63328654\/izaf115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/8\/2311\/63328654\/izaf115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:44:28Z","timestamp":1755035068000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/8\/2311\/8145493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,24]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf115","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,24]]}}}